Gaiane M. Rauch MD, PhD, Presenter: Nothing to Disclose

Leonardo Pimentel Marcal MD, Abstract Co-Author: Nothing to Disclose

Randy Devereux Ernst MD, Abstract Co-Author: Nothing to Disclose

Piyaporn Boonsirikamchai MD, Abstract Co-Author: Nothing to Disclose

Ann Klopp MD, PhD, Abstract Co-Author: Nothing to Disclose

Haesun Choi MD, Abstract Co-Author: Consultant, Novartis AG

Harmeet Kaur MD, Abstract Co-Author: Nothing to Disclose

To present our optimized high resolution (HR) pelvic MRI protocol, using thin section double oblique T2-, 3D T2-, and diffusion-weighted (DWI) imaging techniques for initial staging of cervical and endometrial cancer. To discuss clinical impact of modified HR MRI protocol on treatment approach.  

Review of HR MRI techniques that are used for the pretreatment staging of cervical and endometrial cancer. Present double oblique HR T2 -, 3D T2- and DWI sequences and discuss their benefit over routine HR MRI, particularly in evaluating of the parametrial invasion and nodal disease. Discuss clinical impact of proposed HR MRI modifications on treatment planning (surgery versus chemoradiation) in comparison to the routine HR MRI. Review technical limitations.  

Addition of double oblique T2-, 3D T2-, and DWI sequences to routine HR pelvic MRI provides more accurate staging information in patients with cervical and endometrial carcinomas than use of the routine HR MRI protocol alone. Optimized HR MRI protocol provides clinicians with necessary information for correct treatment planning.

Rauch, G, Marcal, L, Ernst, R, Boonsirikamchai, P, Klopp, A, Choi, H, Kaur, H, Optimization of High-Resolution MRI Technique for Pretreatment Staging of the Cervical and Endometrial Cancer.  Radiological Society of North America 2011 Scientific Assembly and Annual Meeting, November 26 - December 2, 2011 ,Chicago IL. http://archive.rsna.org/2011/11005437.html